Mass B, et al. (2022) Increased Nuclear Localization of Engineered Hsp104 Variants Mitigates aS, FUS, and TDP-43 Toxicity in Yeast. FASEB J 36 Suppl 1.
Jones RD, et al. (2020) The extent of Ssa1/Ssa2 Hsp70 chaperone involvement in nuclear protein quality control degradation varies with the substrate. Mol Biol Cell 31(3):221-233 PMID:31825716
Sweeny EA, et al. (2020) Structural and mechanistic insights into Hsp104 function revealed by synchrotron X-ray footprinting. J Biol Chem 295(6):1517-1538 PMID:31882541
Ye X, et al. (2020) Structural and kinetic basis for the regulation and potentiation of Hsp104 function. Proc Natl Acad Sci U S A 117(17):9384-9392 PMID:32277033
Michalska K, et al. (2019) Structure of Calcarisporiella thermophila Hsp104 Disaggregase that Antagonizes Diverse Proteotoxic Misfolding Events. Structure 27(3):449-463.e7 PMID:30595457
Shorter J and Southworth DR (2019) Spiraling in Control: Structures and Mechanisms of the Hsp104 Disaggregase. Cold Spring Harb Perspect Biol 11(8) PMID:30745294
Tariq A, et al. (2019) Mining Disaggregase Sequence Space to Safely Counter TDP-43, FUS, and α-Synuclein Proteotoxicity. Cell Rep 28(8):2080-2095.e6 PMID:31433984
Ye X, et al. (2019) Hydrogen exchange reveals Hsp104 architecture, structural dynamics, and energetics in physiological solution. Proc Natl Acad Sci U S A 116(15):7333-7342 PMID:30918129
March ZM, et al. (2016) Prion-like domains as epigenetic regulators, scaffolds for subcellular organization, and drivers of neurodegenerative disease. Brain Res 1647:9-18 PMID:26996412
Sweeny EA and Shorter J (2016) Mechanistic and Structural Insights into the Prion-Disaggregase Activity of Hsp104. J Mol Biol 428(9 Pt B):1870-85 PMID:26608812
Yokom AL, et al. (2016) Spiral architecture of the Hsp104 disaggregase reveals the basis for polypeptide translocation. Nat Struct Mol Biol 23(9):830-7 PMID:27478928
Desantis ME, et al. (2014) Conserved distal loop residues in the Hsp104 and ClpB middle domain contact nucleotide-binding domain 2 and enable Hsp70-dependent protein disaggregation. J Biol Chem 289(2):848-67 PMID:24280225
Jackrel ME and Shorter J (2014) Potentiated Hsp104 variants suppress toxicity of diverse neurodegenerative disease-linked proteins. Dis Model Mech 7(10):1175-84 PMID:25062688
Jackrel ME and Shorter J (2014) Reversing deleterious protein aggregation with re-engineered protein disaggregases. Cell Cycle 13(9):1379-83 PMID:24694655
Cushman-Nick M, et al. (2013) Hsp104 suppresses polyglutamine-induced degeneration post onset in a drosophila MJD/SCA3 model. PLoS Genet 9(9):e1003781 PMID:24039611
Shorter J and Taylor JP (2013) Disease mutations in the prion-like domains of hnRNPA1 and hnRNPA2/B1 introduce potent steric zippers that drive excess RNP granule assembly. Rare Dis 1:e25200 PMID:25002999
Torrente MP and Shorter J (2013) The metazoan protein disaggregase and amyloid depolymerase system: Hsp110, Hsp70, Hsp40, and small heat shock proteins. Prion 7(6):457-63 PMID:24401655
Armakola M, et al. (2012) Inhibition of RNA lariat debranching enzyme suppresses TDP-43 toxicity in ALS disease models. Nat Genet 44(12):1302-9 PMID:23104007
DeSantis ME, et al. (2012) Operational plasticity enables hsp104 to disaggregate diverse amyloid and nonamyloid clients. Cell 151(4):778-793 PMID:23141537
Duennwald ML, et al. (2012) Small heat shock proteins potentiate amyloid dissolution by protein disaggregases from yeast and humans. PLoS Biol 10(6):e1001346 PMID:22723742
Shorter J (2011) The mammalian disaggregase machinery: Hsp110 synergizes with Hsp70 and Hsp40 to catalyze protein disaggregation and reactivation in a cell-free system. PLoS One 6(10):e26319 PMID:22022600
Sun Z, et al. (2011) Molecular determinants and genetic modifiers of aggregation and toxicity for the ALS disease protein FUS/TLS. PLoS Biol 9(4):e1000614 PMID:21541367
Cushman M, et al. (2010) Prion-like disorders: blurring the divide between transmissibility and infectivity. J Cell Sci 123(Pt 8):1191-201 PMID:20356930
Roberts BE, et al. (2009) A synergistic small-molecule combination directly eradicates diverse prion strain structures. Nat Chem Biol 5(12):936-46 PMID:19915541
Lo Bianco C, et al. (2008) Hsp104 antagonizes alpha-synuclein aggregation and reduces dopaminergic degeneration in a rat model of Parkinson disease. J Clin Invest 118(9):3087-97 PMID:18704197
Sadlish H, et al. (2008) Hsp110 chaperones regulate prion formation and propagation in S. cerevisiae by two discrete activities. PLoS One 3(3):e1763 PMID:18335038
Shorter J and Lindquist S (2008) Hsp104, Hsp70 and Hsp40 interplay regulates formation, growth and elimination of Sup35 prions. EMBO J 27(20):2712-24 PMID:18833196
Wang H, et al. (2008) Direct and selective elimination of specific prions and amyloids by 4,5-dianilinophthalimide and analogs. Proc Natl Acad Sci U S A 105(20):7159-64 PMID:18480256
Wendler P, et al. (2007) Atypical AAA+ subunit packing creates an expanded cavity for disaggregation by the protein-remodeling factor Hsp104. Cell 131(7):1366-77 PMID:18160044
Shorter J and Lindquist S (2006) Destruction or potentiation of different prions catalyzed by similar Hsp104 remodeling activities. Mol Cell 23(3):425-38 PMID:16885031
Shorter J and Lindquist S (2004) Hsp104 catalyzes formation and elimination of self-replicating Sup35 prion conformers. Science 304(5678):1793-7 PMID:15155912